These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37468213)

  • 21. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of the Pain Medication Questionnaire to predict aberrant urine drug tests: Results from a longitudinal cohort study.
    Morasco BJ; Iacocca MO; Lovejoy TI; Dobscha SK; Deyo RA; Cavese JA; Hyde S; Yarborough BJH
    Psychol Serv; 2021 Aug; 18(3):319-327. PubMed ID: 32673038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain.
    Starrels JL; Fox AD; Kunins HV; Cunningham CO
    J Gen Intern Med; 2012 Nov; 27(11):1521-7. PubMed ID: 22815062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries.
    Friedman S; Patel K; Liu Y; Hartzell S; Keller MS
    Subst Use Misuse; 2020; 55(14):2314-2320. PubMed ID: 32835582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine drug testing: current recommendations and best practices.
    Owen GT; Burton AW; Schade CM; Passik S
    Pain Physician; 2012 Jul; 15(3 Suppl):ES119-33. PubMed ID: 22786451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urine Drug Testing in Cancer Pain Management.
    Arthur JA
    Oncologist; 2020 Feb; 25(2):99-104. PubMed ID: 32043770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinician Ordering and Management Patterns of Urine Toxicology Results at a Cancer Center.
    Yusufov M; Melanson SEF; Kang P; Kematick B; Schiff GD; Chua IS
    J Pain Symptom Manage; 2024 Jul; 68(1):e36-e45. PubMed ID: 38599533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiles of Urine Drug Test in Clinical Pain Patients vs Pain Research Study Subjects.
    Lee CT; Vo TT; Cohen AS; Ahmed S; Zhang Y; Mao J; Chen L
    Pain Med; 2016 Apr; 17(4):636-43. PubMed ID: 26398237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Describing prescription opioid adherence among individuals with chronic pain using urine drug testing.
    Matteliano D; Chang YP
    Pain Manag Nurs; 2015 Feb; 16(1):51-9. PubMed ID: 24939349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM; Goldberger BA; Bertholf RL
    J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated Quantitative Urine Toxicology Analysis May Improve Chronic Pain Patient Compliance with Opioid Therapy.
    Knezevic NN; Khan OM; Beiranvand A; Candido KD
    Pain Physician; 2017 Feb; 20(2S):S135-S145. PubMed ID: 28226335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using urine drug testing to support healthy boundaries in clinical care.
    Heit HA; Gourlay DL
    J Opioid Manag; 2015; 11(1):7-12. PubMed ID: 25750160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine Drug Test Results Among Adolescents and Young Adults in an Outpatient Office-Based Opioid Treatment Program.
    Ramey OL; Bonny AE; Silva Almodóvar A; Nahata MC
    J Adolesc Health; 2023 Jul; 73(1):141-147. PubMed ID: 37031090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in Nevada primary care clinicians' use of urine drug testing to mitigate opioid harm.
    Hartzell SYT; Keller MS; Albertson EM; Liu Y; Larson M; Friedman S
    J Subst Use Addict Treat; 2023 Feb; 145():208940. PubMed ID: 36880912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility and application of urine drug testing in chronic pain management with opioids.
    Nafziger AN; Bertino JS
    Clin J Pain; 2009 Jan; 25(1):73-9. PubMed ID: 19158549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
    Turner JA; Saunders K; Shortreed SM; Rapp SE; Thielke S; LeResche L; Riddell KM; Von Korff M
    J Gen Intern Med; 2014 Feb; 29(2):305-11. PubMed ID: 24142119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results.
    Chua I; Petrides AK; Schiff GD; Ransohoff JR; Kantartjis M; Streid J; Demetriou CA; Melanson SEF
    J Gen Intern Med; 2020 Jan; 35(1):283-290. PubMed ID: 31713040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic.
    Arthur JA; Edwards T; Lu Z; Reddy S; Hui D; Wu J; Liu D; Williams JL; Bruera E
    Cancer; 2016 Dec; 122(23):3732-3739. PubMed ID: 27509305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlates of opiate misuse based on aberrant urine drug tests for patients on chronic opiate therapy in a safety-net, academic primary care clinic.
    Bakhai S; Thilagar B; Reynolds JL; Leonard KE
    J Opioid Manag; 2018; 14(1):23-33. PubMed ID: 29508893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.